Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; purified water; purified talc; iron oxide red; gelatin; titanium dioxide; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: purified talc; titanium dioxide; gelatin; purified water; sodium lauryl sulfate; pregelatinised maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 300 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; pregelatinised maize starch; titanium dioxide; iron oxide red; purified talc; purified water; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 25 mg - capsule, hard - excipient ingredients: gelatin; sodium lauryl sulfate; pregelatinised maize starch; purified water; titanium dioxide; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - lyzalon (pregabalin) is indicated for the treatment of neuropathic pain in adults.,lyzalon (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Ireland - English - HMA (Heads of Medicines Agencies)

veyx-pharma gmbh - peforelin 75 µg/ml - solution for injection - pigs - releasing hormones

Ireland - English - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - flutamide - tablets - 250 milligram - anti-androgens

Malta - English - Medicines Authority

dompe farmaceutici spa via san martino 12, 20122, milan, italy - ketoprofen lysine - oromucosal solution - ketoprofen lysine 1.6 % (w/v) - stomatological preparations

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

birzeit pharmaceutical company (bpc) - clobetasol (clobetasol propionate) - solution for topical use - 0,5mg/ml

Singapore - English - HSA (Health Sciences Authority)

cochlear limited - ear, nose & throat - to provide auditory sensation and sound perception by electrically stimulating the auditory nerve. indications: a. individuals aged 12mth to 17yrs with clinically established bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. b. individuals aged 18yrs and older with clinically established postlinguistic bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. c. prelinguistically or perilinguistically deafened individuals aged 18yrs and older who have profound bilateral sensorineural hearing loss and compromised hearing with hearing aids.

Singapore - English - HSA (Health Sciences Authority)

cochlear limited - ear, nose & throat - to provide auditory sensation and sound perception by electrically stimulating the auditory nerve. indications: a. individuals aged 12mth to 17yrs with clinically established bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. b. individuals aged 18yrs and older with clinically established postlinguistic bilateral or unilateral sensorineural hearing loss and who have compromised functional hearing or would receive no benefit with hearing aids. typical preoperative threshold levels in the impaired ears demonstrate a pure-tone average loss of moderately severe to profound degree. c. prelinguistically or perilinguistically deafened individuals aged 18yrs and older who have profound bilateral sensorineural hearing loss and compromised hearing with hearing aids.